Please contact us using a relevant form below. We’ll get back to you as soon as possible.
Your Name *
Your Email *
Your Phone number *
Therapeutic Goods Administration
t: 1800 020 653
Office for Medicinal Cannabis (OMC)
t: +31 70 340 51 13
For all media enquiries, you can reach us at firstname.lastname@example.org.
For ordering placebo material or if you are looking for herbal medicinal cannabis as an active pharmaceutical ingredient (API), please contact our sales representatives at email@example.com.
If you are seeking our advice in setting up clinical studies with herbal cannabis or cannabis-based products, please contact our experts at firstname.lastname@example.org.
9640 CA Veendam
t: +31 598 62 37 31
Associate Professor Sean Myles: ‘Avoid using sativa/indica terminology’ https://t.co/hcdb0bzca6 https://t.co/lPuXvOkZ52- Thursday Jun 14 - 3:00pm
DJ and cannabis activist Chelsea Leyland produces a documentary about epilepsy to foster more understanding… https://t.co/twAfJ8KZD2- Wednesday Jun 13 - 9:33am
YouTube has put an age restriction on our company movie, because “it may not be appropriate for a general audience”… https://t.co/KTAEha0jIw- Friday Apr 20 - 11:00am
3 days ago
Pure CBD should not be scheduled within the international drug control conventions as the substance was not found to have psychoactive properties, and presents no potential for abuse or dependence. This is one of the recommendations from the 40th Expert Committee on Drug Dependence (ECDD). The ECDD is an independent group of experts in the field of drug dependence convened by WHO. Its role is to advise on the scheduling of substances. WHO then makes recommendations to the UN Secretary General, and the decision whether to adopt the recommendations is subject to a vote by the UN Commission on Narcotic Drugs.http://www.who.int/medicines/access/controlled-substances/en/ ... See MoreSee Less
1 week ago
The application process for accessing medicinal cannabis in Australia has been streamlined. Currently, NSW, Victoria and Queensland are the only states who are able to be applied to simultaneously via the online system. Other states and territories will be included shortly. https://buzzfeed.com/bradesposito/australia-cannabis-access-online-tga/… ... See MoreSee Less
Australia's Medical Cannabis 48-Hour Application Scheme Has Been Rolled Out In NSW, Victoria, And Queensland
1 month ago
Our Business Development Analyst is charged with monitoring, analysing and improving our business. Do you know an expert as we are now hiring. Check the website for more details. https://bedrocan.com/about-us/career/ ... See MoreSee Less
Career - Bedrocan - beyond pioneering
We thought you would be interested in this story from The Times Magazine: Inside the cannabis factory that gives hope for Alfie Dingley and Billy Caldwellhttps://www.thetimes.co.uk/article/c6299c8a-7ead-11e8-af03-7edc8dc9d023 ... See MoreSee Less
Inside the cannabis factory that gives hope for Alfie Dingley and Billy Caldwell
2 months ago
Naturally Bedrocan is represented at the annual symposium of the International Cannabinoid Research Society (ICRS). The 28th edition is being held in Leiden, and that's where our CEO Tjalling Erkelens handed over the first copy of 'A primer to medicinal cannabis' to Heather Bradshaw, president of the ICRS. The booklet is meant to give health care professionals, regulators and patients insights into the medical and scientific aspects of Cannabis sativa L. and how this plant fits in the chain of therapeutic options. 'A primer to medicinal cannabis' is downloadable on our website. ... See MoreSee Less
View on Facebook
We're not around right now. But you can send us an email and we'll get back to you, asap.
Start typing and press Enter to search
Sind Sie Apotheker, und Sie möchten Cannabis bestellen?
Klicken Sie hier